Article Text

Download PDFPDF

LSO-097 Captopril preventing blood brain barrier breach by anti-smith antibody
  1. Yoshiyuki Arinuma,
  2. Kenji Oku and
  3. Kunihiro Yamaoka
  1. Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan


Background Breakdown of the blood-brain barrier (BBB) integrity is required for the development of psychiatric manifestations in SLE (NPSLE), especially in lupus psychosis for the direct attack by autoantibodies against neurons. The aim of this study is to investigate the direct effect of anti-Smith antibody (anti-Sm) on BBB integrity via matrix metalloproteinase (MMP)-2 and evaluate the effect of captopril, a MMP-2 inhibitor on preventing BBB breach.

Methods Human umbilical vein endothelial cells (HUVEC) were stimulated with monoclonal anti-Sm or anti-RNP antibody (anti-RNP). BBB integrity was evaluated with claudin-5 expression, the tight junction composing protein by q-PCR, and western blot. MMP-2 activity was measured by gelatin zymography.

Results Antibody stimulation with anti-Sm or anti-RNP did not affect the expression of MMP-2 and claudin-5 at mRNA level. However, Claudin-5 protein expression was significantly reduced by anti-Sm stimulation compared to isotype control (p=0.004), but not by anti-RNP (p=0.496) (figure 1A). Active MMP-2 in culture supernatant was significantly increased after anti-Sm stimulation (p=0.015), but not by anti-RNP (p=0.688) (figure 1B). Addition of captopril restored claudin-5 mRNA expression that was reduced by anti-Sm stimulation (p=0.031) (figure 1C).

Conclusions Anti-Sm reduced claudin-5 expression in HUVEC through up-regulation of active MMP-2 expression. Our results suggest that Captopril can be protective for BBB breaches mediated by anti-Sm in patients with NPSLE.

Abstract LSO-097 Figure 1

Claudin-5 and active MMP-2

  • autoantibody
  • blood brain barrier

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.